|
1
|
Davis-Searles PR, Nakanishi Y, Kim NC,
Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R and Kroll DJ:
Milk thistle and prostate cancer: differential effects of pure
flavonolignans from Silybum marianum on antiproliferative
end points in human prostate carcinoma cells. Cancer Res.
65:4448–4457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaur M, Velmurugan B, Tyagi A, Deep G,
Katiyar S, Agarwal C and Agarwal R: Silibinin suppresses growth and
induces apoptotic death of human colorectal carcinoma LoVo cells in
culture and tumor xenograft. Mol Cancer Ther. 8:2366–2374. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim S, Choi JH, Lim HI, Lee SK, Kim WW,
Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ and Lee JE: Silibinin
prevents TPA-induced MMP-9 expression and VEGF secretion by
inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast
cancer cells. Phytomedicine. 16:573–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim S, Lee HS, Lee SK, Kim SH, Hur SM, Kim
JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE and Nam SJ:
12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth
arrest is increased by silibinin by the down-regulation of cyclin
B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231
human breast cancer cells. Phytomedicine. 17:1127–1132. 2010.
|
|
5
|
Provinciali M, Papalini F, Orlando F,
Pierpaoli S, Donnini A, Morazzoni P, Riva A and Smorlesi A: Effect
of the silybin-phosphatidylcholine complex (IdB 1016) on the
development of mammary tumors in HER-2/neu transgenic mice. Cancer
Res. 67:2022–2029. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frasca F, Vigneri P, Vella V, Vigneri R
and Wang JY: Tyrosine kinase inhibitor STI571 enhances thyroid
cancer cell motile response to hepatocyte growth factor. Oncogene.
20:3845–3856. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Webb DJ, Donais K, Whitmore LA, Thomas SM,
Turner CE, Parsons JT and Horwitz AF: FAK-Src signalling through
paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell
Biol. 6:154–161. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geho DH, Bandle RW, Clair T and Liotta LA:
Physiological mechanisms of tumor-cell invasion and migration.
Physiology. 20:194–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
11
|
Fingleton B: Matrix metalloproteinases:
roles in cancer and metastasis. Front Biosci. 11:479–491. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giambernardi TA, Grant GM, Taylor GP, Hay
RJ, Maher VM, McCormick JJ and Klebe RJ: Overview of matrix
metalloproteinase expression in cultured human cells. Matrix Biol.
16:483–496. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS,
Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ and Shao ZM: Prognostic
value of matrix metalloproteinases (MMP-2 and MMP-9) in patients
with lymph node-negative breast carcinoma. Breast Cancer Res Treat.
88:75–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim S, Choi JH, Lim HI, Lee SK, Kim WW,
Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE and Yang JH:
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway,
but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell
line. Cell Signal. 21:892–898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Detjen KM, Brembeck FH, Welzel M, Kaiser
A, Haller H, Wiedenmann B and Rosewicz S: Activation of protein
kinase Calpha inhibits growth of pancreatic cancer cells via
p21(cip)-mediated G(1) arrest. J Cell Sci. 113:3025–3035.
2000.PubMed/NCBI
|
|
17
|
Kikkawa U, Takai Y, Tanaka Y, Miyake R and
Nishizuka Y: Protein kinase C as a possible receptor protein of
tumor-promoting phorbol esters. J Biol Chem. 258:11442–11445.
1983.PubMed/NCBI
|
|
18
|
Okabe K, Kato K, Teranishi M, Okumura M,
Fukui R, Mori T, Fukushima N and Tsujiuchi T: Induction of
lysophosphatidic acid receptor-3 by
12-O-tetradecanoylphorbol-13-acetate stimulates cell
migration of rat liver cells. Cancer Lett. 309:236–242. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CW, Shen SC, Chien CC, Yang LY, Shia
LT and Chen YC: 12-O-tetradecanoylphorbol-13-acetate-induced
invasion/migration of glioblastoma cells through activating
PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression. J Cell Physiol.
225:472–481. 2010.
|
|
21
|
Ala-aho R and Kähäri VM: Collagenases in
cancer. Biochimie. 87:273–286. 2005. View Article : Google Scholar
|
|
22
|
Bjorklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
23
|
Devy L, Huang L, Naa L, Yanamandra N,
Pieters H, Frans N, Chang E, Tao Q, Vanhove M, Lejeune A, van Gool
R, Sexton DJ, Kuang G, Rank D, Hogan S, Pazmany C, Ma YL,
Schoonbroodt S, Nixon AE, Ladner RC, Hoet R, Henderikx P, Tenhoor
C, Rabbani SA, Valentino ML, Wood CR and Dransfield DT: Selective
inhibition of matrix metalloproteinase-14 blocks tumor growth,
invasion, and angiogenesis. Cancer Res. 69:1517–1526. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
25
|
Nakajima M, Welch DR, Wynn DM, Tsuruo T
and Nicolson GL: Serum and plasma M(r) 92,000 progelatinase levels
correlate with spontaneous metastasis of rat 13762NF mammary
adenocarcinoma. Cancer Res. 53:5802–5807. 1993.PubMed/NCBI
|
|
26
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappa B
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000.
|
|
27
|
Sen T, Dutta A and Chatterjee A:
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B
(MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human
breast cancer cell line MDA-MB-231. Anticancer Drugs. 21:632–644.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maeda-Yamamoto M, Suzuki N, Sawai Y,
Miyase T, Sano M, Hashimoto-Ohta A and Isemura M: Association of
suppression of extracellular signal-regulated kinase
phosphorylation by epigallocatechin gallate with the reduction of
matrix metalloproteinase activities in human fibrosarcoma HT1080
cells. J Agric Food Chem. 51:1858–1863. 2003. View Article : Google Scholar
|
